MARKET WIRE NEWS

Evolv Technology Reports Fourth Quarter Financial Results

MWN-AI** Summary

Evolv Technology Holdings, Inc. (NASDAQ: EVLV) reported strong financial results for the fourth quarter of 2025, highlighting significant growth across key metrics. The company achieved a revenue of $38.5 million in Q4, a remarkable 32% increase year-over-year from $29.1 million in Q4 2024. This surge was attributed to the addition of new customers and expanded service deployments with existing clients. The Annual Recurring Revenue (ARR) also climbed to $120.5 million, up 21% from the prior year.

Evolv posted a net income of $10.9 million for Q4 2025, marking a substantial turnaround from a net loss of $15.7 million in the same quarter of 2024. The company’s net profit margin stood at 28%, underscoring improved financial health. Adjusted EBITDA for the fourth quarter reached $1.8 million, up from $0.4 million in Q4 2024, with an adjusted EBITDA margin of 5%.

For the full year, Evolv reported a total revenue of $145.9 million, reflecting a 40% increase compared to $103.9 million in 2024. The company narrowed its net loss to $33.1 million for the year, significantly reduced from a loss of $54.0 million in 2024. Adjusted EBITDA for the year turned positive, marking a key milestone in operational efficiency.

Looking ahead, Evolv projects revenues of $172 million to $178 million for 2026, anticipating growth of approximately 18% to 22%. With an optimistic outlook for its AI-driven security solutions and a model shift towards subscriptions, the company aims to capitalize on the growing demand for advanced security technologies in various public spaces. The upcoming financial conference call will provide further insights into Evolv's strategic plans.

MWN-AI** Analysis

Evolv Technology (NASDAQ: EVLV) recently reported strong fourth-quarter results for 2025, showcasing a 32% year-over-year revenue increase to $38.5 million alongside positive net income of $10.9 million, reflecting its potential for sustainable growth. Key metrics, such as an Annual Recurring Revenue (ARR) of $120.5 million—up 21%—clearly indicate increasing traction in its AI-driven security solutions.

Evolv's innovative approach to weapons screening solutions via AI is a significant differentiator as security concerns remain a priority across various sectors. With over 1,200 clients globally, the company capitalizes on a robust recurring revenue model, which is vital for long-term operational stability. The company's transition towards a subscription-based revenue model is expected to enhance predictability in cash flows, further supported by an anticipated ARR growth of 20-25% by year-end 2026.

Moreover, Evolv's projected total revenues for 2026 are estimated to be between $172 million to $178 million, indicating continued strong growth momentum. Importantly, the company aims to achieve positive Adjusted EBITDA in 2026, with margins expected to improve to the high single digits, a substantial leap from the previous year.

From an investment perspective, investors should closely monitor Evolv’s upward trajectory but remain cautious due to its historical losses. A positive net income in Q4 2025 marks a crucial turning point; however, the operational landscape remains competitive. Trading at around $1.06 per share, investors might consider accumulating shares to capitalize on potential growth while balancing risks associated with evolving market dynamics in the security technology space.

In conclusion, Evolv Technology presents a promising opportunity for growth-oriented investors looking into the AI security sector. The company’s ability to sustain growth, achieve profitability, and innovate in a pressing market sets a solid foundation for future success.

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Source: Business Wire

— Company Raises Outlook for 2026 —

  • Q4'25 Revenue of $38.5 million, up 32% year-over-year
  • Q4'25 Ending ARR 1 of $120.5 million, up 21% year-over-year
  • Q4'25 Net Income of $10.9 million, with Net Profit Margin of 28%
  • Q4'25 Adjusted EBITDA 2 of $1.8 million, with Adjusted EBITDA Margin 2 of 5%
  • Q4'25 Ending Cash, Cash Equivalents and Marketable Securities of $69.0 million, up $12.8 million sequentially

Evolv Technologies Holdings, Inc (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the year ended December 31, 2025.

“We are pleased to be reporting solid fourth quarter results, which capped a year of significant improvement across the Company,” said John Kedzierski, President and Chief Executive Officer of Evolv Technology. ”We continue to deliver advanced weapons screening capabilities at scale for more than 1,200 customers worldwide through a tightly integrated platform that combines proprietary hardware, real-world visitor data sets, and AI-driven software, delivered via long-term subscriptions that foster durable customer relationships and high-quality recurring revenue. Looking ahead, we believe AI-based weapons screening will continue to become increasingly prevalent, and we look forward to capitalizing on this still-nascent market opportunity to help make the world a safer place to live, work, learn, and play."

Results for the Fourth Quarter of 2025

Total revenue for the fourth quarter of 2025 was $38.5 million, an increase of 32% compared to $29.1 million for the fourth quarter of 2024. Revenue for the fourth quarter of 2025 was primarily driven by strong new customer additions and continued expansion of deployments across the existing customer base. Annual Recurring Revenue (“ARR”) 1 was $120.5 million at the end of fourth quarter of 2025, an increase of 21% compared to $99.4 million at the end of the fourth quarter of 2024. Net income for the fourth quarter of 2025 was $10.9 million, or $0.06 per basic share and $0.06 per diluted share, compared to net loss of $(15.7) million, or $(0.10) per basic and diluted share, in the fourth quarter of 2024. Adjusted earnings (loss) 2 for the fourth quarter of 2025 was $(5.3) million, or $(0.03) per diluted share, compared to adjusted earnings (loss) 2 of $(4.4) million, or $(0.03) per diluted share, for the fourth quarter of 2024. Adjusted EBITDA 2 for the fourth quarter of 2025 was $1.8 million compared to $0.4 million in the fourth quarter of 2024. As of December 31, 2025, the Company had cash, cash equivalents and marketable securities of $69.0 million.

Results for 2025

Total revenue for the twelve months ended December 31, 2025 was $145.9 million, an increase of 40% compared to $103.9 million for the twelve months ended December 31, 2024. Net loss for the twelve months ended December 31, 2025 was $(33.1) million, or $(0.20) per basic and diluted share, compared to $(54.0) million, or $(0.34) per basic and diluted share, in the twelve months ended December 31, 2024. Adjusted earnings (loss) 2 for the twelve months ended December 31, 2025 was $(16.8) million, or $(0.10) per diluted share, compared to adjusted earnings (loss) 2 of $(35.3) million, or $(0.23) per diluted share, for the twelve months ended December 31, 2024. Adjusted EBITDA 2 for the twelve months ended December 31, 2025 was $11.1 million compared to $(21.0) million in the twelve months ended December 31, 2024.

The following table summarizes the breakdown of recurring and non-recurring revenue 3 for each period presented:

Three Months Ended
December 31,

Twelve Months Ended
December 31,

2025

2024

% Change

2025

2024

% Change

Recurring revenue

$

29,547

$

23,678

25

%

$

112,098

$

87,419

28

%

Non-recurring revenue

8,957

5,422

65

%

33,807

16,446

106

%

Total revenue

$

38,504

$

29,100

32

%

$

145,905

$

103,865

40

%

The following table summarizes operating cash flows for each period presented:

Twelve Months Ended
December 31,

2025

2024

Net loss

$

(33,138

)

$

(54,017

)

Adjustments to reconcile net loss to net cash provided by operating activities

38,542

22,504

Changes in operating assets and liabilities

13,265

660

Net cash provided by (used in) operating activities

$

18,669

$

(30,853

)

Company Comments on Outlook for 2026

The Company today commented on its business outlook for 2026. The Company's outlook is based on the current indications for its business, which may change at any time. The Company expects total revenues in 2026 to be between $172 to $178 million, reflecting growth of approximately 18% to 22% year-over-year. The Company expects ending ARR at December 31, 2026 to increase to approximately $145 to $150 million, reflecting growth of approximately 20% to 25% year-over-year. The Company continues to expect ARR growth to exceed total revenue growth as previously disclosed changes to the Company's selling model and pricing continue to reshape contractual revenue recognition toward a higher mix of recurring revenue and reduced one-time revenue. The Company currently expects approximately 50% of the Company’s new unit deployments in 2026 to be delivered under the Company’s pure subscription model, with the remaining 50% deployed through the Company’s purchase-subscription model. The Company expects to deliver positive full year Adjusted EBITDA 1 in 2026 with Adjusted EBITDA 1 margins in the high single digits.

Estimate

Issued November 13, 2025

Issued March 10, 2026

Total Revenue (Millions)

$160-$165

$172-$178

Ending ARR at 12/31/26 (Millions)

n/a

$145-$150

Adjusted EBITDA Margin 2

n/a

High Single Digits

Company to Host Live Conference Call and Webcast

The Company’s management team plans to host a live conference call and webcast at 4:30 p.m. Eastern Time today to discuss the financial results as well as management’s outlook for the business. The conference call will be webcast live at http://ir.evolvtechnology.com .

About Evolv Technology

Evolv Technologies Holdings, Inc (NASDAQ: EVLV) is designed to transform human security to make a safer, faster, and better experience for the world’s most iconic venues and companies as well as schools, hospitals, and public spaces, using industry leading artificial intelligence (AI)-powered screening and analytics. Its mission is to transform security to create a safer world to live, work, learn, and play. Evolv has digitally transformed the gateways in many places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv’s advanced systems have scanned more than four billion people since 2019. Evolv has been awarded the U.S. Department of Homeland Security (DHS) SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT) as well as the Security Industry Association (SIA) 2024 New Products and Solutions (NPS) Award in the Law Enforcement/Public Safety/Guarding Systems category, as well as Sport Business Journal’s (SBJ) 2024 awards for “Best In Fan Experience Technology” and “Best In Sports Technology”. Evolv®, Evolv Express®, Evolv Insights®, Evolv Visual Gun Detection™, Evolv eXpedite™, and Evolv Eva™ are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit evolv.com .

1 We define Annual Recurring Revenue , or ARR, as subscription revenue and the recurring service revenue related to purchase subscriptions for the final month of the quarter normalized to a one-year period. Our calculation of ARR is not adjusted for the impact of any known or projected future events (such as customer cancellations, upgrades or downgrades, or price increases or decreases) that may cause any such contract not to be renewed on its existing terms. In addition, the amount of actual revenue that we recognize over any 12-month period is likely to differ from ARR at the beginning of that period, sometimes significantly. This may occur due to new bookings, cancellations, upgrades, downgrades or other changes in pending renewals, as well as the effects of professional services revenue and acquisitions or divestitures. As a result, ARR should be viewed independently of, and not as a substitute for or forecast of, revenue and deferred revenue. Our calculation of ARR may differ from similarly titled metrics presented by other companies.

2 Non-GAAP Financial Measures In this press release, the Company’s adjusted gross profit (loss), adjusted gross margin, adjusted operating expenses, adjusted operating income (loss), adjusted EBITDA, adjusted EBITDA margin, adjusted earnings (loss), and adjusted earnings (loss) per diluted share are not presented in accordance with generally accepted accounting principles (GAAP) and are not intended to be used in lieu of GAAP presentations of results of operations. Adjusted gross profit and adjusted gross margin exclude stock-based compensation expense, amortization of capitalized stock-based compensation, loss on impairment of intangible asset, non-recurring employee restructuring and other separation costs, and non-recurring inventory charges, which management believes provides a more meaningful representation of contribution margin. Adjusted operating expenses is defined as operating expenses less stock-based compensation expense, loss on impairment of leased equipment, non-recurring employee restructuring and other separation costs, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of on-going operating expense levels. Other non-recurring legal and regulatory costs include non-recurring legal, accounting and professional fees related to the internal investigation, subsequent restatement, certain non-recurring regulatory, litigation and legal matters, as well as fees related to the resolution of the Securities and Exchange Commission investigation, net of estimated insurance recoveries. Adjusted operating income (loss), is defined as loss from operations, excluding stock-based compensation expense, amortization of capitalized stock-based compensation, loss on impairment of leased equipment, loss on impairment of intangible asset, non-recurring employee restructuring and other separation costs, non-recurring inventory charges, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of operating results. Adjusted EBITDA and Adjusted EBITDA margin is defined as net income (loss) plus depreciation and amortization, stock-based compensation, interest expense (income), provision for income taxes, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, loss on impairment of leased equipment, loss on impairment of intangible asset, loss on disposal of leased equipment, non-recurring employee restructuring and other separation costs, non-recurring inventory charges, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of operating results. Adjusted earnings (loss) and Adjusted earnings (loss) per diluted share are defined as net income (loss) plus stock-based compensation, amortization of capitalized stock-based compensation, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, loss on impairment of leased equipment, loss on impairment of intangible asset, non-recurring employee restructuring and other separation costs, non-recurring inventory charges, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of operating results. Management presents non-GAAP financial measures because it considers them to be important supplemental measures of performance. Management uses non-GAAP financial measures for planning purposes, including analysis of the Company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management also believes non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company's financial and operating performance. However, non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. We intend to provide non-GAAP financial measures as part of our future earnings discussions and, therefore, the inclusion of non-GAAP financial measures will provide consistency in our financial reporting. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures included in this press release. The Company is unable to provide a reconciliation of Adjusted EBITDA to Net Income (Loss) and Adjusted EBITDA Margin to Net Profit Margin, each measure's most directly comparable GAAP financial measure, on a forward-looking basis without unreasonable effort, because items that impact these GAAP financial measures are not within the Company’s control and/or cannot be reasonably predicted. These items may include, but are not limited to, predicting forward-looking share-based compensation, changes in the fair value of contingent earn out liabilities, changes in the fair value of contingently issuable common stock liabilities and changes in fair value of public warrant liabilities. Such information may have a significant, and potentially unpredictable, impact on the Company’s future financial results.

3 Recurring revenue includes the recurring portion of revenue associated with pure subscription contracts and hardware purchase subscription contracts. Non-recurring revenue includes revenue that is non-recurring in nature, such as product revenue, shipping revenue, and revenue from installation, training, and professional services.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release and related presentation materials other than statements of historical facts, including without limitation statements regarding our strategy, goals, demand for our products, market opportunities, and future financial and operational results. Words such as “believe” “may,” “will,” “expect,” “should,” “could,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “potential,” “continue,” “project,” “target,” “forecast”, “is/are likely to” or the negative of these terms or other similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. The forward-looking statements in this press release and related presentation materials are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the amount of insurance reimbursements expected to be received for defense costs for counsel and consultants in connection with the securities litigation and related Securities and Exchange Commission (the “SEC”) and Department of Justice matters, and the following: our history of losses and ability to reach profitability; our reliance on reseller partners; expectations regarding the Company’s strategies and future financial performance, including its future business plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures; our ability to renew customer contracts, our ability to renew customer contracts at terms favorable to the Company, the Company’s reliance on third party contract manufacturing and distribution, and a global supply chain; the Company recognizes a substantial portion of its revenue ratably over the term of its agreements, and, as a result, downturns or upturns in sales may not be immediately reflected in its operating results; the rate of innovation required to maintain competitiveness in the markets in which the Company competes; the competitiveness of the market in which the Company competes; the failure of our products to detect threats could result in injury or loss of life, which could harm our brand, reputation, and results of operations; the loss of designation of our Evolv Express® system as a Qualified Anti-Terrorism Technology under the Homeland Security SAFETY Act; risks related to our business model, which is predicated, in part, on building a customer base that will generate a recurring stream of revenues through the sale of our subscription contracts; the ability for the Company to obtain, maintain, protect and enforce the Company’s intellectual property rights and use of “open source” software; the concentration of the Company’s revenues on a single solution; the Company’s ability to timely design, produce and launch its solutions, the Company’s ability to invest in growth initiatives and pursue acquisition opportunities; the limited liquidity and trading of the Company’s securities; risks related to existing and changing tax laws; geopolitical risk and changes in applicable laws or regulations; the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; operational risk; risks related to material weaknesses in our internal control over financial reporting and our remediation plans; risks related to increasing attention to and evolving expectations for sustainability initiatives; the impact of fluctuating general economic and market conditions and reductions in spending; the need for additional capital to support business growth, which might not be available on acceptable terms, if at all; and litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on resources. These and other important factors discussed in our most recent report on Form 10-Q or 10-K filed with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. The forward-looking statements in this press release and related presentation materials are based upon information available to us as of the date hereof, and while we believe such information forms a reasonable basis for such statements, it may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.

You should review this press release and the documents that we reference in this press release and related presentation materials with the understanding that our actual future results, levels of activity, performance and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this press release and related presentation materials, whether as a result of any new information, future events or otherwise.

EVOLV TECHNOLOGY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(In thousands, except share and per share data)

(Unaudited)

Three Months Ended
December 31,

Twelve Months Ended
December 31,

2025

2024

2025

2024

Revenue:

Product revenue

$

7,545

$

1,675

$

21,637

$

6,464

Subscription revenue

21,717

17,263

83,839

65,046

Service revenue

8,151

6,564

29,375

23,467

License fee and other revenue

1,091

3,598

11,054

8,888

Total revenue

38,504

29,100

145,905

103,865

Cost of revenue:

Cost of product revenue

7,825

2,166

24,320

10,735

Cost of subscription revenue

8,971

8,604

36,684

27,846

Cost of service revenue

2,657

1,476

8,410

5,225

Cost of license fee and other revenue

423

113

1,189

597

Total cost of revenue

19,876

12,359

70,603

44,403

Gross profit

18,628

16,741

75,302

59,462

Operating expenses:

Research and development

5,412

5,390

20,619

23,446

Sales and marketing

11,132

13,455

45,626

60,637

General and administrative

10,069

16,759

54,858

56,602

Restructuring costs

2,662

860

Loss on impairment of property and equipment

15

224

Total operating expenses

26,613

35,619

123,765

141,769

Loss from operations

(7,985

)

(18,878

)

(48,463

)

(82,307

)

Other income, net:

Interest expense

(1,018

)

(1,732

)

Interest income

487

548

1,536

2,942

Other income (expense), net

(18

)

(50

)

99

(83

)

Change in fair value of contingent earn-out liability

10,138

1,218

12,435

16,310

Change in fair value of contingently issuable/returnable common stock liability/asset

2,683

311

2,614

2,529

Change in fair value of public warrant liability

6,595

1,131

435

6,592

Total other income, net

18,867

3,158

15,387

28,290

Loss before income taxes

10,882

(15,720

)

(33,076

)

(54,017

)

Provision for income taxes

$

62

$

Net income (loss)

$

10,882

$

(15,720

)

$

(33,138

)

$

(54,017

)

Net income (loss) income attributable to common stockholders – basic and diluted

$

10,810

$

(15,720

)

$

(33,138

)

$

(54,017

)

Weighted average common shares outstanding

Basic

174,625,931

158,997,410

168,419,211

156,573,886

Diluted

189,125,126

158,997,410

168,419,211

156,573,886

Net income (loss) per share

Basic

$

0.06

$

(0.10

)

$

(0.20

)

$

(0.34

)

Diluted

$

0.06

$

(0.10

)

$

(0.20

)

$

(0.34

)

Net income (loss)

$

10,882

$

(15,720

)

$

(33,138

)

$

(54,017

)

Other comprehensive (loss) income

Cumulative translation adjustment

(4

)

96

(109

)

21

Total other comprehensive (loss) income

(4

)

96

(109

)

21

Total comprehensive income (loss)

$

10,878

$

(15,624

)

$

(33,247

)

$

(53,996

)

EVOLV TECHNOLOGY

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

(Unaudited)

December 31, 2025

December 31, 2024

Assets

Current assets:

Cash and cash equivalents

$

49,150

$

37,015

Marketable securities

19,885

14,927

Accounts receivable, net

30,841

28,392

Inventory

9,317

16,963

Current portion of contract assets

878

799

Current portion of commission asset

6,062

5,429

Prepaid expenses and other current assets

35,169

17,921

Total current assets

151,302

121,446

Contract assets, noncurrent

15

657

Commission asset, noncurrent

7,867

7,567

Property and equipment, net

127,522

123,661

Operating lease right-of-use assets

12,303

13,993

Other assets

5,400

735

Total assets

$

304,409

$

268,059

Liabilities and Stockholders’ Equity

Current liabilities:

Accounts payable

$

9,770

$

10,492

Accrued expenses and other current liabilities

35,293

19,508

Current portion of deferred revenue

74,924

64,506

Current portion of operating lease liabilities

2,989

2,203

Total current liabilities

122,976

96,709

Deferred revenue, noncurrent

16,716

20,266

Long-term debt

28,596

Operating lease liabilities, noncurrent

10,654

12,326

Contingent earn-out liability, noncurrent

374

12,809

Contingently issuable common stock liability, noncurrent

1,809

4,001

Public warrant liability, noncurrent

3,862

4,297

Total liabilities

184,987

150,408

Stockholders’ equity:

Preferred stock, $0.0001 par value; 100,000,000 authorized at December 31, 2025 and December 31, 2024; no shares issued and outstanding at December 31, 2025 and December 31, 2024

Common stock, $0.0001 par value; 1,100,000,000 shares authorized at December 31, 2025 and December 31, 2024; 175,399,488 and 159,602,069 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively

18

16

Additional paid-in capital

507,347

472,331

Accumulated other comprehensive loss

(141

)

(32

)

Accumulated deficit

(387,802

)

(354,664

)

Stockholders’ equity

119,422

117,651

Total liabilities and stockholders’ equity

$

304,409

$

268,059

EVOLV TECHNOLOGY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

Twelve Months Ended
December 31,

2025

2024

Cash flows from operating activities:

Net loss

$

(33,138

)

$

(54,017

)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

Depreciation and amortization

24,340

17,375

Write-off of inventory and change in inventory reserve

2,891

2,578

Loss on impairment of property and equipment

224

Loss on impairment of intangible asset

983

Loss on disposal of property and equipment

3,787

Stock-based compensation

21,096

24,756

Non-cash interest expense

482

(Accretion) amortization of (discount) premium on marketable securities, net of change in accrued interest

(126

)

447

Non-cash lease expense

1,690

1,420

Change in allowance for expected credit losses

(134

)

152

Change in fair value of earn-out liability

(12,435

)

(16,310

)

Change in fair value of contingently issuable/returnable common stock liability/asset

(2,614

)

(2,529

)

Change in fair value of public warrant liability

(435

)

(6,592

)

Changes in operating assets and liabilities

Accounts receivable

(2,315

)

(6,997

)

Inventory

9,118

(7,852

)

Commission assets

(933

)

(1,360

)

Contract assets

563

905

Other assets

750

467

Prepaid expenses and other current assets

(22,577

)

(964

)

Accounts payable

3,775

192

Deferred revenue

6,868

12,815

Accrued expenses and other current liabilities

18,902

4,534

Operating lease liability

(886

)

(1,080

)

Net cash provided by (used in) operating activities

18,669

(30,853

)

Cash flows from investing activities:

Development of internal-use software

(5,627

)

(6,125

)

Purchases of property and equipment

(31,367

)

(31,189

)

Purchases of marketable securities

(39,388

)

(29,367

)

Proceeds from maturities of marketable securities

34,556

65,282

Net cash used in investing activities

(41,826

)

(1,399

)

Cash flows from financing activities:

Proceeds from exercise of stock options

9,085

1,809

Proceeds from long-term debt

26,316

Net cash provided by financing activities

35,401

1,809

Effect of exchange rate changes on cash and cash equivalents

(109

)

21

Net increase (decrease) in cash and cash equivalents

12,135

(30,422

)

Cash and cash equivalents

Cash, cash equivalents, and restricted cash at beginning of period

37,015

67,437

Cash and cash equivalents at end of period

$

49,150

$

37,015

EVOLV TECHNOLOGY

SUMMARY OF KEY OPERATING STATISTICS

(Unaudited)

Three Months Ended or as of,

($ in thousands)

March 31,
2024

June 30,
2024

September 30,
2024

December 31,
2024

March 31,
2025

June 30,
2025

September 30,
2025

December 31,
2025

New customers

53

84

52

60

54

63

62

64

Annual recurring revenue

$

79,192

$

87,011

$

93,676

$

99,351

$

105,990

$

110,516

$

117,200

$

120,467

Recurring revenue

$

18,961

$

21,016

$

23,764

$

23,678

$

25,753

$

26,678

$

30,120

$

29,547

The following table includes the Company's remaining performance obligations for the fiscal quarters from December 31, 2024 through September 30, 2025, which have been updated to reflect immaterial adjustments made as part of the Company’s 2025 year end financial reporting process. These changes had no impact on the Company’s statements of operations and comprehensive income (loss), balance sheets, or statements of cash flows for any periods presented.

As of

($ in thousands)

December 31,
2024

March 31,
2025

June 30,
2025

September 30,
2025

December 31,
2025

Remaining performance obligation (as reported)

$

266,704

$

261,233

$

275,451

$

298,560

$

293,589

Adjustment

(7,592

)

(8,444

)

(8,415

)

(8,829

)

Remaining performance obligation (as adjusted)

$

259,112

$

252,789

$

267,036

$

289,731

$

293,589

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP OPERATING EXPENSES TO ADJUSTED OPERATING EXPENSES

(In thousands)

(Unaudited)

Three Months Ended,

March 31,
2024

June 30,
2024

September 30,
2024

December 31,
2024

March 31,
2025

June 30,
2025

September 30,
2025

December 31,
2025

(Restated)

(Restated)

Operating expenses, GAAP

$

34,061

$

37,128

$

34,961

$

35,619

$

33,539

$

33,711

$

29,902

$

26,613

Stock-based compensation

(6,292

)

(7,254

)

(7,263

)

(3,159

)

(4,660

)

(5,265

)

(5,121

)

(5,006

)

Loss on impairment of leased equipment

(209

)

(15

)

Non-recurring employee restructuring and other separation costs

(1,000

)

(2,060

)

(2,137

)

(827

)

(6

)

Other non-recurring legal and regulatory costs

(476

)

(2,185

)

(2,339

)

(7,284

)

(3,561

)

(5,979

)

36

2,225

Adjusted operating expenses

$

27,293

$

26,689

$

25,150

$

23,101

$

23,181

$

21,640

$

24,811

$

23,832

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP GROSS PROFIT TO ADJUSTED GROSS PROFIT, GAAP GROSS MARGIN TO ADJUSTED GROSS MARGIN AND GAAP INCOME (LOSS) FROM OPERATIONS TO ADJUSTED OPERATING INCOME (LOSS)

(In thousands)

(Unaudited)

Three Months Ended
December 31,

Twelve Months Ended
December 31,

2025

2024

2025

2024

Revenue

$

38,504

$

29,100

$

145,905

$

103,865

Cost of revenue

19,876

12,359

70,603

44,403

Gross profit, GAAP

18,628

16,741

75,302

59,462

Stock-based compensation

274

233

1,044

788

Amortization of capitalized stock-based compensation

150

85

474

137

Loss on impairment of intangible asset

983

983

Non-recurring employee restructuring and other separation costs

6

Non-recurring inventory charges

123

2,730

Adjusted gross profit*

$

19,052

$

18,165

$

76,826

$

64,100

Gross margin %

48.4

%

57.5

%

51.6

%

57.2

%

Adjusted gross margin %

49.5

%

62.4

%

52.7

%

61.7

%

*Beginning in the three month period ended September 30, 2025, and on a go-forward basis, management has determined that the loss on disposal of leased equipment should no longer be considered a non-recurring expense, and accordingly, loss on disposal of leased equipment is now reflected within non-GAAP gross margins and adjusted loss from operations.

Three Months Ended
December 31,

Twelve Months Ended
December 31,

2025

2024

2025

2024

Loss from operations, GAAP

$

(7,985

)

$

(18,878

)

$

(48,463

)

$

(82,307

)

Stock-based compensation

5,280

3,392

21,096

24,756

Amortization of capitalized stock-based compensation

150

85

474

137

Loss on impairment of leased equipment

15

224

Loss on impairment of intangible asset

983

983

Non-recurring employee restructuring and other separation costs

2,060

2,976

3,060

Non-recurring inventory charges

123

2,730

Other non-recurring legal and regulatory costs

(2,225

)

7,284

7,279

12,284

Adjusted loss from operations*

$

(4,780

)

$

(4,936

)

$

(16,638

)

$

(38,133

)

*Beginning in the three month period ended September 30, 2025, and on a go-forward basis, management has determined that the loss on disposal of leased equipment should no longer be considered a non-recurring expense, and accordingly, loss on disposal of leased equipment is now reflected within non-GAAP gross margins and adjusted loss from operations.

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EBITDA AND NET PROFIT MARGIN TO ADJUSTED EBITDA MARGIN

(In thousands)

(Unaudited)

Three Months Ended
December 31,

Twelve Months Ended
December 31,

2025

2024

2025

2024

Net income (loss)

$

10,882

$

(15,720

)

$

(33,138

)

$

(54,017

)

Depreciation and amortization

6,481

5,442

24,340

17,375

Stock-based compensation

5,280

3,392

21,096

24,756

Interest expense (income)

531

(548

)

196

(2,942

)

Provision for income taxes

62

Change in fair value of contingent earn-out liability

(10,138

)

(1,218

)

(12,435

)

(16,310

)

Change in fair value of contingently issuable/returnable common stock liability/asset

(2,683

)

(311

)

(2,614

)

(2,529

)

Change in fair value of public warrant liability

(6,595

)

(1,131

)

(435

)

(6,592

)

Loss on impairment of leased equipment

15

224

Loss on impairment of intangible asset

983

983

Loss on disposal of leased equipment

284

3,787

Non-recurring employee restructuring and other separation costs

2,060

2,976

3,060

Non-recurring inventory charges

123

2,730

Other non-recurring legal and regulatory costs

(2,225

)

7,284

7,279

12,284

Adjusted EBITDA

$

1,817

$

371

$

11,114

$

(20,978

)

Net profit margin %

28.3

%

(54.0

)%

(22.7

)%

(52.0

)%

Impact of adjustments from Net loss to Adjusted EBITDA

(23.6

)%

55.3

%

30.3

%

31.8

%

Adjusted EBITDA margin %

4.7

%

1.3

%

7.6

%

(20.2

)%

EVOLV TECHNOLOGY

RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EARNINGS (LOSS)

(In thousands, except share and per share data)

(Unaudited)

Three Months Ended
December 31,

Twelve Months Ended
December 31,

2025

2024

2025

2024

Net income (loss)

$

10,882

$

(15,720

)

$

(33,138

)

$

(54,017

)

Stock-based compensation

5,280

3,392

21,096

24,756

Amortization of capitalized stock-based compensation

150

85

474

137

Change in fair value of contingent earn-out liability

(10,138

)

(1,218

)

(12,435

)

(16,310

)

Change in fair value of contingently issuable/returnable common stock liability/asset

(2,683

)

(311

)

(2,614

)

(2,529

)

Change in fair value of public warrant liability

(6,595

)

(1,131

)

(435

)

(6,592

)

Loss on impairment of leased equipment

15

224

Loss on impairment of intangible asset

983

983

Non-recurring employee restructuring and other separation costs

2,060

2,976

3,060

Non-recurring inventory charges

123

2,730

Other non-recurring legal and regulatory costs

(2,225

)

7,284

7,279

12,284

Adjusted loss

$

(5,329

)

$

(4,438

)

$

(16,797

)

$

(35,274

)

Weighted average common shares outstanding – diluted

174,625,931

158,997,410

168,419,211

156,573,886

Adjusted loss per share – diluted

$

(0.03

)

$

(0.03

)

$

(0.10

)

$

(0.23

)

*Stock-based compensation, amortization of capitalized stock-based compensation, and non-recurring restructuring and other employee separation costs were recorded in the condensed consolidated statements of operations and comprehensive loss (income) as follows. Prior period amounts are being shown for comparative purposes:

Three Months Ended,

March 31,
2024

June 30,
2024

September 30,
2024

December 31,
2024

March 31,
2025

June 30,
2025

September 30,
2025

December 31,
2025

Stock-based compensation:

Cost of product revenue

$

$

5

$

4

$

8

$

8

$

17

$

32

$

39

Cost of subscription revenue

91

110

169

154

137

167

146

135

Cost of service revenue

44

51

63

61

67

74

72

80

Cost of license fee and other revenue

3

7

8

10

7

24

19

20

Research and development

902

1,222

1,243

1,153

1,115

1,154

1,227

1,252

Sales and marketing

2,959

2,724

2,516

2,747

1,048

1,710

1,480

1,330

General and administrative

2,431

3,308

3,504

(741

)

1,972

2,401

2,414

2,424

Restructuring costs

525

Total stock-based compensation

$

6,430

$

7,427

$

7,507

$

3,392

$

4,879

$

5,547

$

5,390

$

5,280

Amortization of capitalized stock-based compensation:

Cost of subscription revenue

$

8

$

8

$

13

$

47

$

59

$

60

$

63

$

82

Cost of service revenue

6

7

10

38

44

47

51

68

Total amortization of capitalized stock-based compensation

$

14

$

15

$

23

$

85

$

103

$

107

$

114

$

150

Non-recurring employee restructuring and other separation costs:

Cost of service revenue

$

$

$

$

$

$

6

$

$

Research and development

31

Sales and marketing

140

63

613

6

General and administrative

1,997

183

Restructuring costs

860

2,137

Total non-recurring employee restructuring and other separation costs

$

$

1,000

$

$

2,060

$

2,137

$

833

$

6

$

View source version on businesswire.com: https://www.businesswire.com/news/home/20260310341542/en/

Investor Relations:
Brian Norris
Senior Vice President of Finance and Investor Relations
bnorris@evolvtechnology.com

FAQ**

How does Evolv Technologies Holdings Inc. (NASDAQ: EVLV) plan to sustain its impressive revenue growth of 40% in 2025 and project 18%-22% growth for 2026 despite the competitive landscape in security technology?

Evolv Technologies Holdings Inc. plans to sustain its impressive revenue growth by leveraging innovative AI-driven security solutions, expanding its customer base, enhancing partnerships, and continuously improving product offerings to meet diverse market needs.

With a projected increase in ending Annual Recurring Revenue (ARR) to $145-$150 million for the year 2026, how does Evolv Technologies Holdings Inc. (NASDAQ: EVLV) envision leveraging its subscription model to enhance customer retention and revenue predictability?

Evolv Technologies Holdings Inc. aims to enhance customer retention and revenue predictability by leveraging its subscription model through consistent service improvements, tailored customer engagements, and scalable solutions that ensure ongoing value delivery and satisfaction.

What strategies will Evolv Technologies Holdings Inc. (NASDAQ: EVLV) implement to achieve its goal of positive Adjusted EBITDA margins in the high single digits by 2026, considering its history of net losses and adjusting operational expenses?

Evolv Technologies will focus on scaling its AI-driven security solutions, streamlining operational expenses, expanding market reach, enhancing sales efficiency, and fostering strategic partnerships to achieve high single-digit Adjusted EBITDA margins by 2026.

Can Evolv Technologies Holdings Inc. (NASDAQ: EVLV) elaborate on how it plans to manage risks outlined in its financial projections, particularly regarding customer contract renewals and the potential impacts of geopolitical factors on business operations?

Evolv Technologies plans to mitigate risks in financial projections by diversifying its customer base, implementing robust contract management strategies, and proactively assessing geopolitical factors to ensure operational resilience and adapt to market changes.

**MWN-AI FAQ is based on asking OpenAI questions about Evolv Technologies Holdings Inc. (NASDAQ: EVLV).

Evolv Technologies Holdings Inc.

NASDAQ: EVLV

EVLV Trading

-2.03% G/L:

$5.315 Last:

4,739,622 Volume:

$5.49 Open:

mwn-ir Ad 300

EVLV Latest News

EVLV Stock Data

$972,619,971
165,654,468
1.33%
78
N/A
Corporate Services
Industrials
US
Waltham

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App